MIG
XBI icon

McGuire Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

McGuire Investment Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$889K Sell
5,618
-1,611
-22% -$218K 0.08% 85
2026
Q1 		$923K Hold
7,229
– – 0.1% 73
2025
Q4 		$881K Sell
7,229
-525
-7% -$60.2K 0.09% 74
2025
Q3 		$777K Sell
7,754
-552
-7% -$49.7K 0.09% 76
2025
Q2 		$689K Sell
8,306
-110,614
-93% -$8.82M 0.09% 74
2025
Q1 		$9.64M Sell
118,920
-68,388
-37% -$6.11M 1.43% 26
2024
Q4 		$16.9M Sell
187,308
-3,164
-2% -$307K 2.44% 15
2024
Q3 		$18.8M Sell
190,472
-2,822
-1% -$277K 2.65% 14
2024
Q2 		$17.9M Buy
193,294
+708
+0.4% +$63.5K 2.57% 13
2024
Q1 		$18.3M Buy
192,586
+3,110
+2% +$289K 2.67% 11
2023
Q4 		$16.9M Sell
189,476
-2,554
-1% -$190K 2.82% 11
2023
Q3 		$14M Buy
192,030
+11,862
+7% +$948K 2.7% 15
2023
Q2 		$15M Sell
180,168
-1,840
-1% -$154K 2.79% 13
2023
Q1 		$13.9M Buy
182,008
+1,906
+1% +$158K 2.76% 13
2022
Q4 		$14.9M Sell
180,102
-9,276
-5% -$751K 3.24% 9
2022
Q3 		$15M Buy
189,378
+5,557
+3% +$468K 3.42% 6
2022
Q2 		$13.7M Buy
183,821
+3,035
+2% +$228K 2.94% 8
2022
Q1 		$16.2M Buy
180,786
+3,105
+2% +$287K 2.98% 8
2021
Q4 		$19.9M Buy
177,681
+16,304
+10% +$1.97M 3.27% 8
2021
Q3 		$20.3M Buy
161,377
+13,403
+9% +$1.73M 3.81% 6
2021
Q2 		$20M Buy
147,974
+16,695
+13% +$2.19M 3.8% 6
2021
Q1 		$17.8M Buy
131,279
+5,407
+4% +$810K 3.76% 5
2020
Q4 		$17.7M Buy
125,872
+15,587
+14% +$2M 4.39% 5
2020
Q3 		$12.3M Buy
110,285
+2,472
+2% +$277K 3.66% 7
2020
Q2 		$12.1M Sell
107,813
-6,843
-6% -$674K 4.19% 5
2020
Q1 		$8.88M Buy
114,656
+18,217
+19% +$1.61M 3.69% 10
2019
Q4 		$9.17M Buy
96,439
+1,660
+2% +$144K 2.72% 13
2019
Q3 		$7.23M Sell
94,779
-26,570
-22% -$2.21M 2.37% 13
2019
Q2 		$10.6M Buy
121,349
+3,023
+3% +$258K 3.37% 8
2019
Q1 		$10.7M Sell
118,326
-860
-0.7% -$73.2K 3.51% 6
2018
Q4 		$8.55M Buy
119,186
+2,084
+2% +$168K 3.23% 9
2018
Q3 		$11.2M Buy
+117,102
New +$11.4M 3.71% 7

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return
G
GenTrust Miami, Florida $2.6B AUM 18.42% 1-Year Est. Return

McGuire Investment Group's XBI Position: Q2 2026 in Review

McGuire Investment Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 22% in Q2 2026, selling an estimated $218K and leaving 5,618 shares worth $889K. The position accounts for 0.08% of the portfolio, ranked #85.

McGuire Investment Group first reported a position in XBI in Q3 2018 and has held it in 32 quarters since. The position peaked at $20.3M in Q3 2021. 523 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • McGuire Investment Group held 5,618 shares of State Street SPDR S&P Biotech ETF worth $889K as of Q2 2026.
  • McGuire Investment Group sold 1,611 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $218K.
  • State Street SPDR S&P Biotech ETF made up 0.08% of McGuire Investment Group's portfolio in Q2 2026, its #85 holding.
  • McGuire Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 32 quarters since.
  • McGuire Investment Group's State Street SPDR S&P Biotech ETF position peaked at $20.3M in Q3 2021.
  • 523 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on McGuire Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.